Endo Revenue 2006-2019 | ENDP

Endo revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Endo Annual Revenue
(Millions of US $)
2018 $2,947
2017 $3,469
2016 $4,010
2015 $3,269
2014 $2,381
2013 $2,125
2012 $2,816
2011 $2,525
2010 $1,716
2009 $1,461
2008 $1,261
2007 $1,086
2006 $910
2005 $820
Endo Quarterly Revenue
(Millions of US $)
Q1 2019 $720
Q4 2018 $786
Q3 2018 $745
Q2 2018 $715
Q1 2018 $701
Q4 2017 $769
Q3 2017 $787
Q2 2017 $876
Q1 2017 $1,038
Q4 2016 $1,242
Q3 2016 $884
Q2 2016 $921
Q1 2016 $964
Q4 2015 $1,074
Q3 2015 $746
Q2 2015 $735
Q1 2015 $714
Q4 2014 $663
Q3 2014 $654
Q2 2014 $593
Q1 2014 $471
Q4 2013 $93
Q3 2013 $661
Q2 2013 $712
Q1 2013 $658
Q4 2012 $589
Q3 2012 $750
Q2 2012 $785
Q1 2012 $691
Q4 2011 $598
Q3 2011 $759
Q2 2011 $608
Q1 2011 $560
Q4 2010 $511
Q3 2010 $444
Q2 2010 $397
Q1 2010 $364
Q4 2009 $391
Q3 2009 $361
Q2 2009 $373
Q1 2009 $335
Q4 2008 $347
Q3 2008 $317
Q2 2008 $306
Q1 2008 $290
Q4 2007 $305
Q3 2007 $269
Q2 2007 $257
Q1 2007 $254
Q4 2006 $259
Q3 2006 $217
Q2 2006 $228
Q1 2006 $205
Q4 2005 $241
Q3 2005 $245
Q2 2005 $196
Q1 2005 $138
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.792B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.414B 34.76
Astellas Pharma (ALPMY) Japan $28.829B 14.14
Takeda Pharmaceutical (TAK) Japan $27.169B 7.98
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.853B 27.26
Grifols, S.A (GRFS) Spain $15.092B 19.09
Merck (MKGAF) Germany $13.293B 18.14
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Ionis Pharmaceuticals (IONS) United States $9.459B 20.68
Sage Therapeutics (SAGE) United States $9.292B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.044B 0.00
Catalent (CTLT) United States $7.834B 31.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 10.69
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Nektar Therapeutics (NKTR) United States $5.574B 9.09
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.818B 16.93
Tilray (TLRY) Canada $4.302B 0.00
Evotec AG (EVTCY) Germany $4.265B 45.78
FibroGen (FGEN) United States $3.980B 0.00
United Therapeutics (UTHR) United States $3.335B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.191B 11.45
Arrowhead Pharmaceuticals (ARWR) United States $2.704B 407.43
PTC Therapeutics (PTCT) United States $2.503B 0.00
Xencor (XNCR) United States $2.493B 68.05
Zogenix (ZGNX) United States $2.019B 0.00
Portola Pharmaceuticals (PTLA) United States $1.763B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.672B 80.96
Ironwood Pharmaceuticals (IRWD) United States $1.639B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.607B 21.97
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.516B 0.00
USANA Health Sciences (USNA) United States $1.412B 12.27
Corcept Therapeutics (CORT) United States $1.226B 17.49
ArQule (ARQL) United States $1.132B 0.00
Aerie Pharmaceuticals (AERI) United States $1.103B 0.00
Radius Health (RDUS) United States $1.038B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.016B 3.66
Theravance Biopharma (TBPH) Cayman Islands $0.994B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.882B 0.00
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.678B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Organogenesis Holdings (ORGO) United States $0.584B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.582B 0.00
TherapeuticsMD (TXMD) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.495B 0.00
Karyopharm Therapeutics (KPTI) United States $0.480B 0.00
ChemoCentryx (CCXI) United States $0.471B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Dermira (DERM) United States $0.460B 0.00
Siga Technologies (SIGA) United States $0.460B 1.08
BioSpecifics Technologies Corp (BSTC) United States $0.455B 22.94
Dova Pharmaceuticals (DOVA) United States $0.452B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.434B 0.00
CV Sciences (CVSI) United States $0.421B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
Indivior (INVVY) United States $0.415B 1.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
CannTrust Holdings (CTST) Canada $0.404B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.396B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.382B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Collegium Pharmaceutical (COLL) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.346B 0.00
ImmunoGen (IMGN) United States $0.339B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Rafael Holdings (RFL) United States $0.294B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Molecular Templates (MTEM) United States $0.276B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Aratana Therapeutics (PETX) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.238B 0.00
Recro Pharma (REPH) United States $0.224B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.223B 0.00
Lannett Co Inc (LCI) United States $0.219B 2.13
Ocular Therapeutix (OCUL) United States $0.206B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.197B 0.00
Redhill Biopharma (RDHL) Israel $0.181B 0.00
Calithera Biosciences (CALA) United States $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Ardelyx (ARDX) United States $0.163B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.148B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
Jounce Therapeutics (JNCE) United States $0.140B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.126B 0.00
DURECT (DRRX) United States $0.113B 0.00
AgeX Therapeutics (AGE) United States $0.110B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.093B 0.00
Capnia (SLNO) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
Mast Therapeutics (SVRA) United States $0.090B 0.00
Genocea Biosciences (GNCA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 62.56
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
MediWound (MDWD) Israel $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Natural Alternatives (NAII) United States $0.081B 8.07
Cardiome Pharma (CORV) Canada $0.080B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
India Globalization Capital (IGC) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00